Bruce Bean
Professor Harvard
Bruce Bean is Robert Winthrop Professor of Neurobiology at Harvard Medical School. Bean graduated from Harvard College, received a Ph.D. in Biophysics from the University of Rochester, did postdoctoral work with Richard W. Tsien at the Yale School of Medicine, and has previously held faculty positions at the University of Iowa and the Vollum Institute of Oregon Health Sciences University. His research interests are in the electrophysiology of neurons and muscle and in using ion channels to develop new therapeutic treatments
Seminars
As the field looks beyond sodium channel blockers and established approaches, identifying the next generation of clinically meaningful pain targets remains a critical challenge. This workshop will explore emerging pain biology, novel therapeutic mechanisms and modern target discovery approaches, with a focus on translating biological insights into validated, drug-ready opportunities.
Key Topics Covered:
- How can human genetics, multi-omics datasets and AIenabled approaches uncover novel pain mechanisms and identify high-priority therapeutic targets?
- What can emerging insights into neuroinflammation, central sensitization, neuronal plasticity and neuroimmune interactions reveal about the drivers of chronic pain?
- Which novel target classes, including neuroimmune pathways, microglial signalling, adenosine receptors, NOX pathways, ATTR-related mechanisms and GLP-1 signalling, show the greatest therapeutic potential?
- How can developers distinguish compelling biology from truly druggable opportunities by assessing causality, tractability, target engagement and translational confidence?
